GB2264949B - Measles virus recombinant poxvirus vaccine - Google Patents

Measles virus recombinant poxvirus vaccine

Info

Publication number
GB2264949B
GB2264949B GB9309414A GB9309414A GB2264949B GB 2264949 B GB2264949 B GB 2264949B GB 9309414 A GB9309414 A GB 9309414A GB 9309414 A GB9309414 A GB 9309414A GB 2264949 B GB2264949 B GB 2264949B
Authority
GB
United Kingdom
Prior art keywords
measles virus
recombinant poxvirus
virus recombinant
poxvirus vaccine
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9309414A
Other versions
GB2264949A (en
GB9309414D0 (en
Inventor
Enzo Paoletti
Jill Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virogenetics Corp
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Priority to GB9500214A priority Critical patent/GB2283021B/en
Publication of GB9309414D0 publication Critical patent/GB9309414D0/en
Publication of GB2264949A publication Critical patent/GB2264949A/en
Application granted granted Critical
Publication of GB2264949B publication Critical patent/GB2264949B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB9309414A 1990-11-20 1991-11-20 Measles virus recombinant poxvirus vaccine Expired - Lifetime GB2264949B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9500214A GB2283021B (en) 1990-11-20 1991-11-20 A recombinant poxviral vaccine for canine distemper

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62161490A 1990-11-20 1990-11-20
US77686791A 1991-10-22 1991-10-22
PCT/US1991/008703 WO1992008789A1 (en) 1990-11-20 1991-11-20 Measles virus recombinant poxvirus vaccine

Publications (3)

Publication Number Publication Date
GB9309414D0 GB9309414D0 (en) 1993-07-14
GB2264949A GB2264949A (en) 1993-09-15
GB2264949B true GB2264949B (en) 1995-07-05

Family

ID=27089007

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9500214A Expired - Lifetime GB2283021B (en) 1990-11-20 1991-11-20 A recombinant poxviral vaccine for canine distemper
GB9309414A Expired - Lifetime GB2264949B (en) 1990-11-20 1991-11-20 Measles virus recombinant poxvirus vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB9500214A Expired - Lifetime GB2283021B (en) 1990-11-20 1991-11-20 A recombinant poxviral vaccine for canine distemper

Country Status (12)

Country Link
JP (2) JP3617668B2 (en)
AU (1) AU1253892A (en)
BE (1) BE1005908A5 (en)
CA (1) CA2096633A1 (en)
CH (1) CH683921A5 (en)
DE (2) DE4192786B4 (en)
FR (1) FR2669346B1 (en)
GB (2) GB2283021B (en)
IE (2) IE68404B1 (en)
IT (1) IT1252687B (en)
NL (2) NL195058C (en)
WO (1) WO1992008789A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338683A (en) 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5505941A (en) * 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US6248333B1 (en) 1990-04-04 2001-06-19 Health Research Inc. Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5989561A (en) * 1991-03-07 1999-11-23 Virogenetics Corporation Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
KR100242671B1 (en) * 1991-03-07 2000-03-02 고돈 에릭 Genetically engineered vaccine strain
AU672581B2 (en) * 1991-03-07 1996-10-10 Virogenetics Corporation Immunodeficiency virus recombinant poxvirus vaccine
JPH06505397A (en) * 1991-03-20 1994-06-23 ヴァイロジェネティクス　コーポレイション malaria recombinant poxvirus
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
CN1089370C (en) * 1994-12-08 2002-08-21 中国预防医学科学研究院病毒学研究所 Recombination vaccinia virus for expression of measles virus L4 strain hemagglutinin and fusion protein gene
AU2118997A (en) * 1996-02-05 1997-08-22 Johns Hopkins University, The Measles immunization by dna transcription unit inoculation
CA2289731A1 (en) 1997-05-09 1998-11-12 The United States Of America, Represented By The Secretary, Department O F Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
EP1095948A1 (en) * 1999-10-28 2001-05-02 Universitätsklinikum Freiburg Idiotype vaccines
CN100446812C (en) * 2001-03-08 2008-12-31 美国国有健康与人类服务部 MVA expressing modified HIV envelope, GAG, and pol genes
AR052743A1 (en) * 2006-04-11 2007-03-28 Inst Nac De Tecnologia Agropec PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305229A1 (en) * 1987-07-07 1989-03-01 Transgene S.A. Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus
WO1989003429A1 (en) * 1987-08-28 1989-04-20 Health Research Inc. Recombinant avipox virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632863B2 (en) * 1987-10-29 1990-08-31 Transgene Sa RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
JPH01218590A (en) * 1988-02-29 1989-08-31 Toa Nenryo Kogyo Kk Rinderpest virus vaccine using recombinant vaccinia virus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305229A1 (en) * 1987-07-07 1989-03-01 Transgene S.A. Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus
WO1989003429A1 (en) * 1987-08-28 1989-04-20 Health Research Inc. Recombinant avipox virus

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
J.gen.Virol. 1988,69,2071-2083 *
J.Virol. 1986,58(2),536-541 *
J.Virol. 1990,64(2),527-533 *
Proc.Natl.Acad.Sci.USA 1988,85,1252-1256 *
Science,Vol 229,1985,pages 981-984 *
Technol.Adv.Vaccine Develop. 1988,321-334 *
Virus Res. 1987,8,373-386 *

Also Published As

Publication number Publication date
GB9500214D0 (en) 1995-03-01
DE4192786B4 (en) 2006-08-24
FR2669346A1 (en) 1992-05-22
CA2096633A1 (en) 1992-05-21
GB2264949A (en) 1993-09-15
JPH06502996A (en) 1994-04-07
FR2669346B1 (en) 1995-07-21
IE71643B1 (en) 1997-02-26
GB2283021B (en) 1995-07-05
DE4192786T1 (en) 1994-01-13
NL195095C (en) 2004-01-21
JP3617668B2 (en) 2005-02-09
AU1253892A (en) 1992-06-11
IT1252687B (en) 1995-06-23
GB9309414D0 (en) 1993-07-14
JP3824619B2 (en) 2006-09-20
NL195058C (en) 2003-07-01
NL9120026A (en) 1993-09-01
CH683921A5 (en) 1994-06-15
BE1005908A5 (en) 1994-03-08
NL9900036A (en) 2003-10-01
JP2005040129A (en) 2005-02-17
GB2283021A (en) 1995-04-26
IE913960A1 (en) 1992-05-20
IE68404B1 (en) 1996-06-12
ITMI913092A0 (en) 1991-11-20
ITMI913092A1 (en) 1993-05-20
WO1992008789A1 (en) 1992-05-29

Similar Documents

Publication Publication Date Title
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
GB9303023D0 (en) Flavivirus recombinant poxvirus vaccine
AU4325089A (en) Viral vaccines
GB2264949B (en) Measles virus recombinant poxvirus vaccine
DE69016956D1 (en) Recombinant turkey herpes virus and derived live vaccine vector.
HU912526D0 (en) Recombinant marek-type disease virus
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
EP0210931A3 (en) Vaccine against varicella-zoster virus
AU1257092A (en) Interferon sensitive recombinant poxvirus vaccine
IL101639A0 (en) Recombinant influenza vaccines
AU5679394A (en) Hepatitis b virus vaccines
EP0575544A4 (en) Malaria recombinant poxvirus vaccine
ZA908189B (en) Infectious bronchitis virus vaccine
AU2347692A (en) Recombinant viral vaccine
EP0537232A4 (en) Recombinant pigeon pox virus vaccine
HU9203976D0 (en) Vaccine based on modified herpes virus
ZA919198B (en) Measles virus recombinant poxvirus vaccine
AU6051396A (en) Measles virus recombinant poxvirus vaccine
FR2648712B1 (en) VACCINE AGAINST BOVINE LEUKEMIA VIRUS
IE892907L (en) Viral vaccines
GB9020799D0 (en) Viral vaccines
ZA902894B (en) Herpesvirus recombinant poxvirus vaccine
GB9109763D0 (en) Herpes virus vaccine
CS77089A1 (en) Adjuvant for virus vaccines
GB8608991D0 (en) Virus vaccine

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20111119